Transition report pursuant to Rule 13a-10 or 15d-10

RELATED PARTY TRANSACTIONS (Details Narrative)

v3.8.0.1
RELATED PARTY TRANSACTIONS (Details Narrative) - USD ($)
1 Months Ended 10 Months Ended 12 Months Ended
Nov. 14, 2017
Jun. 24, 2016
Dec. 20, 2013
Mar. 31, 2017
Jan. 31, 2017
Dec. 31, 2016
Dec. 31, 2017
Feb. 28, 2017
Mr. Andrew I. Sealfon [Member] | Lease Agreement [Member] | Aircraft [Member]                
Lease payments             $ 13,421 $ 21,500
Mr. Mark Pastreich [Member] | Lease Agreement [Member] | Building [Member]                
Monthly lease payments $ 12,088           11,042  
Lease payments             110,420 132,504
Property taxes paid             41,959 48,455
Brad A. Sealfon [Member]                
Officer compensation       $ 2,000 $ 7,744 $ 7,744    
Clinical Research & Support Services Consulting Agreement [Member] | Dr. Mark Baker [Member]                
Amortization of deferred compensation cost             $ 0 28,000
Clinical Research & Support Services Consulting Agreement [Member] | FREEDOM60 Syringe Infusion System [Member] | Dr. Mark Baker [Member]                
Number of shares issued upon agreement     420,000          
Share price (in dollars per share)     $ 0.20          
Agreement term     3 years          
Consulting Agreement [Member] | Mr. Cyril Narishkin (Consultant) [Member]                
Monthly payment for agreement   $ 16,000            
Number of shares repurchased             96,542  
Value of shares repurchased             $ 43,393  
Officer compensation               $ 230,000